Primary Vasculitides: Best Practices and Future Advance - Giant Cell Arteritis is organized by Cleveland Clinic Foundation Center for Continuing Education and will be held from Jun 12, 2017 - Jun 12, 2019.
The target audience for this medical event for rheumatologists, nephrologists, pulmonologists, dermatologists, neurologists, allergists, immunologists, and advanced practice clinicians interested in vasculitis.
This CME Conference has been approved with a maximum of 0.50 AMA PRA Category 1 Credit. Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
Cleveland Clinic R.J. Fasenmyer Center for Clinical Immunology presents Primary Vasculitides: Best Practices and Future Advances online series featuring an update on the current standard of care and management of patients with primary vasculitides. Advances and future development in the treatment of primary vasculitides will be shared by the experts in this field.
This webcast will review current treatment of giant cell arteritis and how to recognize disease chronicity. Treatment-related morbidity and vascular complications will also be discussed.
Conference Objectives are:
• Review current treatment of giant cell arteritis
• Recognize disease chronicity in giant cell arteritis
• Identify treatment-related morbidity in giant cell arteritis
• Assess for vascular complications in giant cell arteritis
Additional details will be posted as soon as they are available.
Immunology and Microbiology, Rheumatology